Indeed, the pathogenesis of AML often involves one or more cytogenetic abnormalities that blocks hematopoietic differentiation combined with mutations in either pro-apoptotic genes, such as TP53, or proliferative kinase genes, such as FLT3, c-Kit, and RAS-related family members. Here, TP53 is linked to acute myeloid leukemia.